171 related articles for article (PubMed ID: 864256)
1. Receptor-binding sites on C3 and C3b.
Dierich MP; Bokisch VA
J Immunol; 1977 Jun; 118(6):2145-50. PubMed ID: 864256
[TBL] [Abstract][Full Text] [Related]
2. Interaction of soluble C3 fragments with guinea pig lymphocytes. Comparison of effects of C3a, C3b, C3c, and C3d on lymphokine production and lymphocyte proliferation.
Koopman WJ; Sandberg AL; Wahl SM; Mergenhagen SE
J Immunol; 1976 Jul; 117(1):331-6. PubMed ID: 932430
[TBL] [Abstract][Full Text] [Related]
3. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
[TBL] [Abstract][Full Text] [Related]
4. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
Davis AE; Harrison RA; Lachmann PJ
J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
[TBL] [Abstract][Full Text] [Related]
5. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
Theofilopoulos AN; Dixon FJ; Bokisch VA
J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225
[TBL] [Abstract][Full Text] [Related]
6. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
[TBL] [Abstract][Full Text] [Related]
7. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.
Atkinson JP; Frank MM
J Clin Invest; 1974 Aug; 54(2):339-48. PubMed ID: 4847248
[TBL] [Abstract][Full Text] [Related]
8. Human lymphocytes bear membrane receptors for C3b and C3d.
Eden A; Miller GW; Nussenzweig V
J Clin Invest; 1973 Dec; 52(12):3239-42. PubMed ID: 4543024
[TBL] [Abstract][Full Text] [Related]
9. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
Gerdes J; Klatt U; Stein H
Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
[TBL] [Abstract][Full Text] [Related]
10. Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin.
Carlo JR; Ruddy S; Studer EJ; Conrad DH
J Immunol; 1979 Aug; 123(2):523-8. PubMed ID: 88474
[TBL] [Abstract][Full Text] [Related]
11. Kinetic studies on the fragmentation of the third component of complement (C3) by trypsin.
Minta JO; Man D; Movat HZ
J Immunol; 1977 Jun; 118(6):2192-8. PubMed ID: 864257
[TBL] [Abstract][Full Text] [Related]
12. Interaction of human lymphocytes with fluid phase human C3b detected by immunofluorescence.
Simonian S; Molenaar JL; Zeijlemaker WP; Knape JT; Bakker S; Pondman KW
Eur J Immunol; 1976 Jan; 6(1):52-6. PubMed ID: 823035
[TBL] [Abstract][Full Text] [Related]
13. Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b.
Meuth JL; Morgan EL; DiSipio RG; Hugli TE
J Immunol; 1983 Jun; 130(6):2605-11. PubMed ID: 6602172
[TBL] [Abstract][Full Text] [Related]
14. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
Lambris JD; Ross GD
J Immunol; 1982 Jan; 128(1):186-9. PubMed ID: 7033372
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
16. Third component of complement (C3): structural properties in relation to functions.
Bokisch VA; Dierich MP; Mūller-Eberhard HJ
Proc Natl Acad Sci U S A; 1975 Jun; 72(6):1989-93. PubMed ID: 1056006
[TBL] [Abstract][Full Text] [Related]
17. Action of the C3b-inactivator on the cell-bound C3b.
Law SK; Fearon DT; Levine RP
J Immunol; 1979 Mar; 122(3):759-65. PubMed ID: 448074
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
[TBL] [Abstract][Full Text] [Related]
19. Membrane receptors of mouse leukocytes. I. Two types of complement receptors for different regions of C3.
Rabellino EM; Ross GD; Polley MJ
J Immunol; 1978 Mar; 120(3):879-85. PubMed ID: 632590
[TBL] [Abstract][Full Text] [Related]
20. C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.
Daha MR; Fearon DT; Austen KF
J Immunol; 1976 Jan; 116(1):1-7. PubMed ID: 1245733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
